|
⚲
|
| Keyboard |
| Lux Ventures IV LP
✚
|
|
|---|---|
| CIK # | 0001633331 |
| EDGAR Form | CIK | 2011 - 2026 |
|---|---|---|
| 3 | [0001633331] | |
| 4 | [0001633331] | |
| D | [0001633331] | |
| SC 13G | [0001633331] |
| Form 13D/13G Filer | Form 13D/13G Subject | Filed |
|---|---|---|
| Lux Ventures IV LP | Latch Inc | [2021-06-14] |
| Insider Transaction (Form 3/4/5) | Date | Action | Shares | Price | Value ($) |
|---|---|---|---|---|---|
|
Aeva Technologies Inc AEVA
Common Stock
|
2022-08-05 | Other | 7,346,159 | $0.00 | |
|
Science 37 Holdings Inc SNCE
Common Stock
|
2022-04-04 | Other | 2,914,667 | $0.00 | |
|
Recursion Pharmaceuticals Inc RXRX
Class A common stock
|
2021-12-07 | Other | 4,265,576 | $0.00 | |
|
Latch Inc LTCH
Common Stock
|
2021-09-28 | Other | 2,409,489 | $0.00 | |
|
Latch Inc LTCH
Common Stock
|
2021-09-28 | Other | 1,358,164 | $0.00 | |
|
Aeva Technologies Inc AEVA
Common Stock
|
2021-09-08 | Other | 7,346,159 | $0.00 | |
|
Recursion Pharmaceuticals Inc RXRX
Class A Common Stock
|
2021-04-20 | Conversion | 17,187,095 | ||
|
Recursion Pharmaceuticals Inc RXRX
Common Stock
|
2021-04-20 | Conversion | 17,187,095 | ||
|
Recursion Pharmaceuticals Inc RXRX
Common Stock
|
2021-04-20 | Conversion | 17,174,594 | ||
|
Recursion Pharmaceuticals Inc RXRX
Series C Preferred Stock · derivative
|
2021-04-20 | Conversion | 1,825,883 | $0.00 | |
|
Recursion Pharmaceuticals Inc RXRX
Series D Preferred Stock · derivative
|
2021-04-20 | Conversion | 1,490,783 | $0.00 | |
|
Recursion Pharmaceuticals Inc RXRX
Series B Preferred Stock · derivative
|
2021-04-20 | Conversion | 3,578,653 | $0.00 | |
|
Recursion Pharmaceuticals Inc RXRX
Series A Preferred Stock · derivative
|
2021-04-20 | Conversion | 10,279,275 | $0.00 | |
|
Recursion Pharmaceuticals Inc RXRX
Class A Common Stock
|
2021-04-16 | Buy | 100,000 | $18.00 | 1,800,000 |